FOR IMMEDIATE RELEASE

Bordetella Blots Registered for Clinical Use

New Laboratory Testing Alternative for Bordetella pertussis

May 2010

Bordetella pertussis ViraStripe IgG: PT-100

The PT-100 band on the Bordetella pertussis ViraStripe^® IgG  is calibrated with International WHO
Standards and - when reactive - presents supportive evidence for a recent contact with Bordetella pertussis when a recent vaccination has been ruled out.

As a Class 1 Device, Viramed Biotech has filed for InVitro Diagnostic use of the B. pertussis Line blot for clinical testing.

Viramed Biotech – Bordetella pertussis IgG ViraStripe ^®

Immunoassay for the qualitative Detection of IgG-specific Antibodies to Bordetella pertussis in Human Serum.

For More Information Contact:

Viralab Incorporated
105 Copperwood Way Suite M, Oceanside CA 92054
Tel: 760.757.1666
FAX: 760.757.1603
Internet: viralabinfo@viralab.us

Send mail to viralab@viralab.us with questions or comments about this web site.
Last modified: 05/27/10